MyChart is not for medical emergencies. If you have a medical emergency, call 911.
If you need help with MyChart, call us at 1-844-442-4278.
Researchers in the Institute for Molecular Engineering at the University of Chicago (IME) have developed a new way to target immunotherapies and deliver them directly to tumors.
Architect Anwar Hakim turned to UChicago Medicine for a second opinion on treatment for advanced melanoma. Oncologist and melanoma expert Jason Luke, MD, suggested a Phase 1 clinical trial of a combination immunotherapy based on UChicago Medicine research. The treatment worked quickly and side effects were minimal, allowing Hakim to maintain a full work and travel schedule while receiving the therapy. "Six years ago, we didn’t have much to offer patients with advanced melanoma," Luke said. "Now we are seeing unbelievable responses to immunotherapy."